Capstone Partners served as a financial advisor to C.B. Fleet Company, Inc. (“Fleet Laboratories”), a portfolio company of Gryphon Investors, in its sale to Prestige Brands for $825 million.
Fleet Laboratories owns a portfolio of iconic brands in the feminine hygiene, gastrointestinal care and infant care categories including Summer’s Eve®, Fleet®, Pedia-Lax®, Phazyme® and Boudreaux’s®.
The Company’s products, which are sold in over 50 countries worldwide, have an unmatched legacy of trust and efficacy with consumers and medical professionals.
This is the fifth transaction in which Capstone Partners has advised Fleet Laboratories.
